139 related articles for article (PubMed ID: 31850227)
1. Survivin Promotes Piperlongumine Resistance in Ovarian Cancer.
Nan XW; Gong LH; Chen X; Zhou HH; Ye PP; Yang Y; Xing ZH; Wei MN; Li Y; Wang ST; Liu K; Shi Z; Yan XJ
Front Oncol; 2019; 9():1345. PubMed ID: 31850227
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-141 enhances anoikis resistance in metastatic progression of ovarian cancer through targeting KLF12/Sp1/survivin axis.
Mak CS; Yung MM; Hui LM; Leung LL; Liang R; Chen K; Liu SS; Qin Y; Leung TH; Lee KF; Chan KK; Ngan HY; Chan DW
Mol Cancer; 2017 Jan; 16(1):11. PubMed ID: 28095864
[TBL] [Abstract][Full Text] [Related]
3. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
[TBL] [Abstract][Full Text] [Related]
4. Piperlongumine induces gastric cancer cell apoptosis and G2/M cell cycle arrest both in vitro and in vivo.
Duan C; Zhang B; Deng C; Cao Y; Zhou F; Wu L; Chen M; Shen S; Xu G; Zhang S; Duan G; Yan H; Zou X
Tumour Biol; 2016 Aug; 37(8):10793-804. PubMed ID: 26874726
[TBL] [Abstract][Full Text] [Related]
5. Piperlongumine Induces Apoptosis in Human Melanoma Cells Via Reactive Oxygen Species Mediated Mitochondria Disruption.
Song X; Gao T; Lei Q; Zhang L; Yao Y; Xiong J
Nutr Cancer; 2018 Apr; 70(3):502-511. PubMed ID: 29543494
[TBL] [Abstract][Full Text] [Related]
6. Piperlongumine-induced nuclear translocation of the FOXO3A transcription factor triggers BIM-mediated apoptosis in cancer cells.
Liu Z; Shi Z; Lin J; Zhao S; Hao M; Xu J; Li Y; Zhao Q; Tao L; Diao A
Biochem Pharmacol; 2019 May; 163():101-110. PubMed ID: 30753811
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine induces G2/M phase arrest and apoptosis in cholangiocarcinoma cells through the ROS-JNK-ERK signaling pathway.
Thongsom S; Suginta W; Lee KJ; Choe H; Talabnin C
Apoptosis; 2017 Nov; 22(11):1473-1484. PubMed ID: 28913568
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine and immune cytokine TRAIL synergize to promote tumor death.
Li J; Sharkey CC; King MR
Sci Rep; 2015 May; 5():9987. PubMed ID: 25984950
[TBL] [Abstract][Full Text] [Related]
9. Piperlongumine Induces Reactive Oxygen Species (ROS)-Dependent Downregulation of Specificity Protein Transcription Factors.
Karki K; Hedrick E; Kasiappan R; Jin UH; Safe S
Cancer Prev Res (Phila); 2017 Aug; 10(8):467-477. PubMed ID: 28673967
[TBL] [Abstract][Full Text] [Related]
10. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
Wang F; Mao Y; You Q; Hua D; Cai D
Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
[TBL] [Abstract][Full Text] [Related]
11. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance.
Han SS; Han S; Kamberos NL
Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702
[TBL] [Abstract][Full Text] [Related]
12. Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells.
Kung FP; Lim YP; Chao WY; Zhang YS; Yu HI; Tai TS; Lu CH; Chen SH; Li YZ; Zhao PW; Yen YP; Lee YR
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503074
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine induces apoptotic and autophagic death of the primary myeloid leukemia cells from patients via activation of ROS-p38/JNK pathways.
Xiong XX; Liu JM; Qiu XY; Pan F; Yu SB; Chen XQ
Acta Pharmacol Sin; 2015 Mar; 36(3):362-74. PubMed ID: 25619389
[TBL] [Abstract][Full Text] [Related]
14. Piperlongumine Induces Cell Cycle Arrest via Reactive Oxygen Species Accumulation and IKKβ Suppression in Human Breast Cancer Cells.
Jeong CH; Ryu H; Kim DH; Cheng WN; Yoon JE; Kang S; Han SG
Antioxidants (Basel); 2019 Nov; 8(11):. PubMed ID: 31739520
[TBL] [Abstract][Full Text] [Related]
15. Piperlongumine induces autophagy in biliary cancer cells via reactive oxygen species-activated Erk signaling pathway.
Chen SY; Huang HY; Lin HP; Fang CY
Int J Mol Med; 2019 Nov; 44(5):1687-1696. PubMed ID: 31485612
[TBL] [Abstract][Full Text] [Related]
16. Piperlongumine, a piper alkaloid targets Ras/PI3K/Akt/mTOR signaling axis to inhibit tumor cell growth and proliferation in DMH/DSS induced experimental colon cancer.
Kumar S; Agnihotri N
Biomed Pharmacother; 2019 Jan; 109():1462-1477. PubMed ID: 30551398
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine suppresses bladder cancer invasion via inhibiting epithelial mesenchymal transition and F-actin reorganization.
Liu D; Qiu XY; Wu X; Hu DX; Li CY; Yu SB; Pan F; Chen XQ
Biochem Biophys Res Commun; 2017 Dec; 494(1-2):165-172. PubMed ID: 29037814
[TBL] [Abstract][Full Text] [Related]
18. Piperlongumine selectively kills glioblastoma multiforme cells via reactive oxygen species accumulation dependent JNK and p38 activation.
Liu JM; Pan F; Li L; Liu QR; Chen Y; Xiong XX; Cheng K; Yu SB; Shi Z; Yu AC; Chen XQ
Biochem Biophys Res Commun; 2013 Jul; 437(1):87-93. PubMed ID: 23796709
[TBL] [Abstract][Full Text] [Related]
19. Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
Zhang Q; Chen W; Lv X; Weng Q; Chen M; Cui R; Liang G; Ji J
Front Pharmacol; 2019; 10():1180. PubMed ID: 31680962
[TBL] [Abstract][Full Text] [Related]
20. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
